Circulating Gonadotropin Surge-Attenuating Factor From Superovulated Women Suppressing In-Vitro Gonadotropin-Releasing-Hormone Self-Priming

Paul Alfred Francois Fowler, P CUNNINGHAM, M Fraser, F MACGREGOR, B BYRNE, A PAPPAS, I E MESSINIS, Allan Templeton

Research output: Contribution to journalArticle

Abstract

A perifusion system based on ovine pituitary tissue explants was used to investigate the effects of follicular fluid (hFF) and serum from superovulated women on pituitary responsiveness to gonadotrophin-releasing hormone (GnRH). The specific aims of the study were to determine both if gonadotrophin surge-attenuating factor (GnSAF) bioactivity is present in the peripheral circulation as well as in the follicles of superovulated women and if GnSAF suppresses GnRH self-priming in vitro. Two pulses of GnRH, 1 h apart, produced marked peaks in LH secreted from control chambers, with GnRH self-priming evident in the significant difference between the first (134.4 +/- 1.7-232.1 +/- 24.0% of basal secretion) and second (183.9 +/- 15.8-313.9 +/- 14.0% of basal secretion) LH peaks. Both follicular fluid and serum pooled from two different groups of women produced marked suppression of the first (unprimed) and second (primed) LH peaks. The hFF reduced the first LH peak to 69.6 +/- 7.8 and 60.2 +/- 9.7% and the second LH peak to 57.4 +/- 6.7 and 42.6 +/- 6.5% of control LH secretion. Overall, the serum reduced the first and second LH peaks to 76.8 +/- 4.2 and 62.9 +/- 3.6% of control respectively. These results demonstrated that GnSAF bioactivity suppresses GnRH self-priming, and is present in both the peripheral circulation and hFF. The same material administered to dispersed ovine pituitary monolayers produced similar marked suppression of GnRH-induced LH secretion, with approximately 50-fold less GnSAF bioactivity in serum compared with hFF. Combined doses of oestradiol and progesterone, or hFF from large follicles containing little GnSAF, produced stimulation of GnRH-induced LH secretion and GnRH self-priming (second peaks 78.1 +/- 38.9 and 27.4 +/- 15.7% respectively higher than first peaks). Thus, in conclusion, GnSAF in hFF and serum markedly attenuated both unprimed and primed pituitary response to GnRH, virtually abolishing the GnRH self-priming effect.

Original languageEnglish
Pages (from-to)45-54
Number of pages10
JournalJournal of Endocrinology
Volume143
Issue number1
Publication statusPublished - Oct 1994

Keywords

  • human follicular-fluid
  • ovine pituitary-cells
  • factor GNSAF
  • inhibiting factor
  • menstrual-cycle
  • stimulating-hormone
  • positive feedback
  • 2 pools
  • secretion
  • invitro

Cite this

Circulating Gonadotropin Surge-Attenuating Factor From Superovulated Women Suppressing In-Vitro Gonadotropin-Releasing-Hormone Self-Priming. / Fowler, Paul Alfred Francois; CUNNINGHAM, P ; Fraser, M ; MACGREGOR, F ; BYRNE, B ; PAPPAS, A ; MESSINIS, I E ; Templeton, Allan.

In: Journal of Endocrinology, Vol. 143, No. 1, 10.1994, p. 45-54.

Research output: Contribution to journalArticle

@article{f818dccf5e2341209995ee370456f352,
title = "Circulating Gonadotropin Surge-Attenuating Factor From Superovulated Women Suppressing In-Vitro Gonadotropin-Releasing-Hormone Self-Priming",
abstract = "A perifusion system based on ovine pituitary tissue explants was used to investigate the effects of follicular fluid (hFF) and serum from superovulated women on pituitary responsiveness to gonadotrophin-releasing hormone (GnRH). The specific aims of the study were to determine both if gonadotrophin surge-attenuating factor (GnSAF) bioactivity is present in the peripheral circulation as well as in the follicles of superovulated women and if GnSAF suppresses GnRH self-priming in vitro. Two pulses of GnRH, 1 h apart, produced marked peaks in LH secreted from control chambers, with GnRH self-priming evident in the significant difference between the first (134.4 +/- 1.7-232.1 +/- 24.0{\%} of basal secretion) and second (183.9 +/- 15.8-313.9 +/- 14.0{\%} of basal secretion) LH peaks. Both follicular fluid and serum pooled from two different groups of women produced marked suppression of the first (unprimed) and second (primed) LH peaks. The hFF reduced the first LH peak to 69.6 +/- 7.8 and 60.2 +/- 9.7{\%} and the second LH peak to 57.4 +/- 6.7 and 42.6 +/- 6.5{\%} of control LH secretion. Overall, the serum reduced the first and second LH peaks to 76.8 +/- 4.2 and 62.9 +/- 3.6{\%} of control respectively. These results demonstrated that GnSAF bioactivity suppresses GnRH self-priming, and is present in both the peripheral circulation and hFF. The same material administered to dispersed ovine pituitary monolayers produced similar marked suppression of GnRH-induced LH secretion, with approximately 50-fold less GnSAF bioactivity in serum compared with hFF. Combined doses of oestradiol and progesterone, or hFF from large follicles containing little GnSAF, produced stimulation of GnRH-induced LH secretion and GnRH self-priming (second peaks 78.1 +/- 38.9 and 27.4 +/- 15.7{\%} respectively higher than first peaks). Thus, in conclusion, GnSAF in hFF and serum markedly attenuated both unprimed and primed pituitary response to GnRH, virtually abolishing the GnRH self-priming effect.",
keywords = "human follicular-fluid, ovine pituitary-cells, factor GNSAF, inhibiting factor, menstrual-cycle, stimulating-hormone, positive feedback, 2 pools, secretion, invitro",
author = "Fowler, {Paul Alfred Francois} and P CUNNINGHAM and M Fraser and F MACGREGOR and B BYRNE and A PAPPAS and MESSINIS, {I E} and Allan Templeton",
year = "1994",
month = "10",
language = "English",
volume = "143",
pages = "45--54",
journal = "Journal of Endocrinology",
issn = "0022-0795",
publisher = "Society for Endocrinology",
number = "1",

}

TY - JOUR

T1 - Circulating Gonadotropin Surge-Attenuating Factor From Superovulated Women Suppressing In-Vitro Gonadotropin-Releasing-Hormone Self-Priming

AU - Fowler, Paul Alfred Francois

AU - CUNNINGHAM, P

AU - Fraser, M

AU - MACGREGOR, F

AU - BYRNE, B

AU - PAPPAS, A

AU - MESSINIS, I E

AU - Templeton, Allan

PY - 1994/10

Y1 - 1994/10

N2 - A perifusion system based on ovine pituitary tissue explants was used to investigate the effects of follicular fluid (hFF) and serum from superovulated women on pituitary responsiveness to gonadotrophin-releasing hormone (GnRH). The specific aims of the study were to determine both if gonadotrophin surge-attenuating factor (GnSAF) bioactivity is present in the peripheral circulation as well as in the follicles of superovulated women and if GnSAF suppresses GnRH self-priming in vitro. Two pulses of GnRH, 1 h apart, produced marked peaks in LH secreted from control chambers, with GnRH self-priming evident in the significant difference between the first (134.4 +/- 1.7-232.1 +/- 24.0% of basal secretion) and second (183.9 +/- 15.8-313.9 +/- 14.0% of basal secretion) LH peaks. Both follicular fluid and serum pooled from two different groups of women produced marked suppression of the first (unprimed) and second (primed) LH peaks. The hFF reduced the first LH peak to 69.6 +/- 7.8 and 60.2 +/- 9.7% and the second LH peak to 57.4 +/- 6.7 and 42.6 +/- 6.5% of control LH secretion. Overall, the serum reduced the first and second LH peaks to 76.8 +/- 4.2 and 62.9 +/- 3.6% of control respectively. These results demonstrated that GnSAF bioactivity suppresses GnRH self-priming, and is present in both the peripheral circulation and hFF. The same material administered to dispersed ovine pituitary monolayers produced similar marked suppression of GnRH-induced LH secretion, with approximately 50-fold less GnSAF bioactivity in serum compared with hFF. Combined doses of oestradiol and progesterone, or hFF from large follicles containing little GnSAF, produced stimulation of GnRH-induced LH secretion and GnRH self-priming (second peaks 78.1 +/- 38.9 and 27.4 +/- 15.7% respectively higher than first peaks). Thus, in conclusion, GnSAF in hFF and serum markedly attenuated both unprimed and primed pituitary response to GnRH, virtually abolishing the GnRH self-priming effect.

AB - A perifusion system based on ovine pituitary tissue explants was used to investigate the effects of follicular fluid (hFF) and serum from superovulated women on pituitary responsiveness to gonadotrophin-releasing hormone (GnRH). The specific aims of the study were to determine both if gonadotrophin surge-attenuating factor (GnSAF) bioactivity is present in the peripheral circulation as well as in the follicles of superovulated women and if GnSAF suppresses GnRH self-priming in vitro. Two pulses of GnRH, 1 h apart, produced marked peaks in LH secreted from control chambers, with GnRH self-priming evident in the significant difference between the first (134.4 +/- 1.7-232.1 +/- 24.0% of basal secretion) and second (183.9 +/- 15.8-313.9 +/- 14.0% of basal secretion) LH peaks. Both follicular fluid and serum pooled from two different groups of women produced marked suppression of the first (unprimed) and second (primed) LH peaks. The hFF reduced the first LH peak to 69.6 +/- 7.8 and 60.2 +/- 9.7% and the second LH peak to 57.4 +/- 6.7 and 42.6 +/- 6.5% of control LH secretion. Overall, the serum reduced the first and second LH peaks to 76.8 +/- 4.2 and 62.9 +/- 3.6% of control respectively. These results demonstrated that GnSAF bioactivity suppresses GnRH self-priming, and is present in both the peripheral circulation and hFF. The same material administered to dispersed ovine pituitary monolayers produced similar marked suppression of GnRH-induced LH secretion, with approximately 50-fold less GnSAF bioactivity in serum compared with hFF. Combined doses of oestradiol and progesterone, or hFF from large follicles containing little GnSAF, produced stimulation of GnRH-induced LH secretion and GnRH self-priming (second peaks 78.1 +/- 38.9 and 27.4 +/- 15.7% respectively higher than first peaks). Thus, in conclusion, GnSAF in hFF and serum markedly attenuated both unprimed and primed pituitary response to GnRH, virtually abolishing the GnRH self-priming effect.

KW - human follicular-fluid

KW - ovine pituitary-cells

KW - factor GNSAF

KW - inhibiting factor

KW - menstrual-cycle

KW - stimulating-hormone

KW - positive feedback

KW - 2 pools

KW - secretion

KW - invitro

M3 - Article

VL - 143

SP - 45

EP - 54

JO - Journal of Endocrinology

JF - Journal of Endocrinology

SN - 0022-0795

IS - 1

ER -